Register Now-NACFC 2017

November 2, 2017

The Emerging Role of CFTR Combination Regimens in Improving Outcomes for Patients With Cystic Fibrosis

Click here to register
CME/CNE Seminar

Thursday, November 2, 2017
7:30 - 8:00 pm Registration and Dinner
8:00 - 9:45 pm CME/CNE Seminar

JW Marriott Indianapolis
White River Ballroom F-J
10 South West Street
Indianapolis, Indiana

FACULTY

John P. Clancy, MD (Chair)
Professor of Pediatrics

Director, Pulmonary Medicine Research

Co-Director, CF Research Development Program

Medical Director, Office of Clinical and Translational Research Gunnar Esiason/Cincinnati Bell Chair in Life Sciences Research Division of Pulmonary Medicine

Cincinnati Children's Hospital Medical Center

Cincinnati, Ohio

Prof. Jane Davies

Professor of Paediatric Respirology and Experimental Medicine

Imperial College London

Honorary Consultant in Paediatric Respiratory Medicine

Royal Brompton and Harefield NHS Foundation Trust

London, United Kingdom

Carlos Milla, MD

Professor and Director

The Stanford Cystic Fibrosis Center

Associate Director for Translational Research

Center for Excellence in Pulmonary Biology

Stanford University

Palo Alto, California

Kristin A. Riekert, PhD

Associate Professor

Director, Johns Hopkins Adherence Research Center

Director, Cystic Fibrosis Adherence Program

Johns Hopkins School of Medicine

Baltimore, Maryland

Gregory Sawicki, MD, MPH

Director, Cystic Fibrosis Center

Boston Children's Hospital

Assistant Professor of Pediatrics

Harvard Medical School

Boston, Massachusetts

Jennifer L. Taylor-Cousar, MD, MSCS

Medical Director, Clinical Research Services

Co-Director and CF TDN Director, Adult CF Program

Associate Professor, Departments of Medicine and Pediatrics,

Divisions of Pulmonary, Critical Care and Sleep Medicine and Pediatric Pulmonary Medicine

Denver, Colorado

PROGRAM OVERVIEW

This live, inter professional continuing education seminar will highlight the latest advances in CFTR-based therapeutics for the treatment of patients with cystic fibrosis. The expert faculty will utilize an interactive panel format to present and discuss recent trial data as it relates to clinical decision-making, including updates regarding the assessment, monitoring, and management of patients treated with CFTR modulated therapies. This educational activity is intended to increase the knowledge and competencies of the multidisciplinary team involved in the care of the CF patient population. Upon completion of this educational activity, the healthcare team will be better equipped with vital information for improving outcomes and quality of life in patients with cystic fibrosis.

AGENDA

8:00 – 8:05 pm   Welcome and Introductions

John P. Clancy, MD

8:05 – 8:15 pm   Case Vignette – Early Diagnosis Through NBS and Early Intervention

Prof. Jane Davies

8:15 – 8:30 pm   Update on Cystic Fibrosis Science: From the Gene to the Patient

Jennifer L. Taylor-Cousar, MD, MSCS

8:30 – 8:35 pm   Interactive Panel Discussion

John P. Clancy, MD & Expert Panel

8:35 – 8:50 pm   Clinical Trial Analysis of CFTR Modulators: New Populations, New

                           Developments

Carlos Milla, MD

8:50– 9:05 pm   Longer Term Outcomes of CFTR Modulator Use in the Clinic

Gregory Sawicki, MD, MPH

9:05 – 9:10 pm   Interactive Panel Discussion

John P. Clancy, MD & Expert Panel

9:10 – 9:25 pm   A Personalized Approach to Patient Management

Kristin A. Riekert, PhD

9:25 – 9:45 pm   Clinical Vignettes Questions and Final Discussion

John P. Clancy, MD & Expert Panel

LEARNING OUTCOMES STATEMENT

At the conclusion of this activity:
KNOWLEDGE: Participants will self-report knowledge gained based on current best practices for improving outcomes and quality of life in patients with cystic fibrosis.
COMPETENCE/SKILL: Participants will self-report intent to change practice by applying current best practices for improving outcomes and quality of life in patients with cystic fibrosis.

EDUCATIONAL OBJECTIVES

Upon completion of this activity, participants will be better able to do the following:

  1. Review pathophysiology, genomic evaluation and functional implications of CF, including the underlying causes of disease to guide therapeutic selection
  2. Examine clinical trial data of emerging combination therapies for the treatment of CF
  3. Implement a data-driven and personalized CFTR modulated treatment plan to improve the life-long management of patients with CF

CME Credit (Physicians)

The Elsevier Office of Continuing Medical Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Elsevier Office of Continuing Medical Education designates this live activity for a maximum of 1.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CNE Credit (Nurses)

Elsevier will award 1.75 contact hours for this activity. No partial credit will be given. Elsevier is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Elsevier is provider approved by the Florida Board of Nursing, Provider #50-4681, and the California Board of Registered Nursing, Provider #CEP 3257.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of EOCME, Elsevier, and AcademicCME. EOCME is accredited by the ACCME to provide continuing medical education for physicians.

TARGET AUDIENCE

This activity has been designed to meet the educational needs of health care professionals involved in the diagnosis, treatment, or management of patients with cystic fibrosis.

FEE INFORMATION

There is no registration fee for attending this symposium.

CME INQUIRIES AND SPECIAL NEEDS

Event staff will be glad to assist you with any special needs (physical, dietary, etc.). Please contact AcademicCME prior to the live event at admin@academiccme.com or 610-687-3300.

FINANCIAL SUPPORT

This activity is supported by an independent educational grant from Vertex Pharmaceuticals Incorporated.

PARTNER INFORMATION

Provided in collaboration with Elsevier Office of Continuing Medical Education, Elsevier and AcademicCME.

EVENT DATE: Thursday, November 2, 2017

Starts: 7:30 pm (Dinner)
E
nds: 9:45 pm

LOCATION:

JW Marriott Indianapolis
White River Ballroom F-J
10 South West Street
Indianapolis, Indiana

You will receive an email confirmation shortly after you complete the registration.

If you are unable to register online or do not receive your confirmation email after registering (don't forget to check your spam email folder), please email elsevierCME@elsevier.com

Click here to register
CME/CNE Seminar

Course summary
Available credit: 
  • 1.75 AMA PRA Category 1 Credit(s)™
  • 1.75 Nursing Contact Hours
  • 1.75 Non-physician
Course opens: 
09/27/2017
Course expires: 
11/03/2017
Event starts: 
11/02/2017 - 7:30pm
Event ends: 
11/02/2017 - 9:45pm
Rating: 
0

Available Credit

  • 1.75 AMA PRA Category 1 Credit(s)™
  • 1.75 Nursing Contact Hours
  • 1.75 Non-physician

Accreditation Period

Course opens: 
09/27/2017
Course expires: 
11/03/2017
Please login or register to take this course.